These findings align with previous studies showing that reducing SAMHD1 expression improves ara-C response.67,68 Our data support a novel personalized approach to enhance the anti-cancer effects of ara-C by combining it with HSP90 inhibitors. This evidence concerns the gene SAMHD1 and cancer.